Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Panjon Inhaler is an over-the-counter Ayurvedic nasal decongestant manufactured by Panjon Limited, an Indian consumer goods company. It is formulated as a portable inhaler containing a blend of aromatic ingredients, typically including menthol, camphor, and essential oils such as eucalyptus oil. The product is intended to provide temporary relief from nasal congestion associated with the common cold, hay fever, or other upper respiratory allergies by providing a cooling sensation and promoting the feeling of clearer breathing. It is not a biotech drug candidate but rather a traditional consumer healthcare product marketed for its immediate symptomatic relief properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Panjon Inhaler.